Genetics and calcium nephrolithiasis

Kidney International

Volumn 80, Issue 6, 2011, Pages 587-593

  Vezzoli, Giuseppe ^a   Terranegra, Annalisa ^b   Arcidiacono, Teresa ^a   Soldati, Laura ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

calcium sensing receptor; calciuria; citraturia; gene expression; kidney stones

Indexed keywords

ADENYLATE CYCLASE; CALCIDIOL 1 MONOOXYGENASE; CALCIUM; CALCIUM SENSING RECEPTOR; CHLORIDE CHANNEL; CITRIC ACID; CLAUDIN; CLAUDIN 14; CLAUDIN 16; CLAUDIN 19; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INWARDLY RECTIFYING POTASSIUM CHANNEL; OSTEOCALCIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PROTON COUPLED FOLATE TRANSPORTER; PROTON PUMP; SODIUM PHOSPHATE COTRANSPORTER 2C; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG; UROKINASE; UVOMORULIN; VANILLOID RECEPTOR 6; VITAMIN D RECEPTOR;

ATP6B1 GENE; ATP6N1B GENE; CALCIUM NEPHROLITHIASIS; CASE CONTROL STUDY; CASR GENE; CLCN5 GENE; CLDN14 GENE; CLDN16 GENE; CLDN19 GENE; DISEASE COURSE; DISEASE SEVERITY; FAMILY STUDY; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HIGH THROUGHPUT SCREENING; HUMAN; HYPERCALCIURIA; KCNJ1 GENE; NEPHROLITHIASIS; OCG GENE; OCRL1 GENE; OPN GENE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SLC12A1 GENE; SLC34A3 GENE; SLC4A1 GENE; STONE FORMATION; TRPV6 GENE; UMOD GENE; VDD1 GENE; VDR GENE;

EID: 80052264848     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.430     Document Type: Short Survey

References (57)

1. Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med 1968; 278: 1313-1318.
2. McGeown MG. Heredity in renal stone disease. Clin Sci 1960; 19: 465-471.
3. Goldfarb DS, Fischer ME, Keich Y et al. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005; 67: 1053-1061. (Pubitemid 41623330)
4. Goodman HO, Brommage R, Assimos DG et al. Genes in idiopathic calcium oxalate stone disease. World J Urol 1997; 15: 186-194. (Pubitemid 127764005)
5. Loredo-Osti JC, Roslin NM, Tessier J et al. Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int 2005; 68: 966-971. (Pubitemid 43246413)
6. Cho HY, Lee BL, Choi HJ et al. Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol 2008; 23: 243-249.
7. Scheinman SJ, Cox JPD, Lloyd SE et al. Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int 2000; 57: 232-239. (Pubitemid 30227770)
8. Muller D, Kausalya PI, Claverie-Martin F et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 2003; 73: 1293-1301. (Pubitemid 38037423)
9. Konrad M, Schaller A, Seelow D et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006; 79: 949-957. (Pubitemid 44763409)
10. Smith AN, Skaug J, Choate KA et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 2000; 26: 71-75.
11. Karet FE, Finberg KE, Nelson RD et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 1999; 21: 84-90. (Pubitemid 29036289)
12. Bruce LJ, Cope DL, Jones GK et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (band 3, AE1) gene. J Clin Invest 1997; 100: 1693-1707. (Pubitemid 27431325)
13. Bergwitz C, Roslin NM, Tieder M et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 2006; 78: 179-192. (Pubitemid 43157559)
14. Tencza AL, Ichikawa S, Dang A et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/Type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis. J Clin Endocrinol Metab 2009; 94: 4433-4438.
15. Pearce SH, Williamson C, Kifor O et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calciumsensing receptor. New Eng J Med 1996; 335: 1115-1122. (Pubitemid 26330965)
16. Puricelli E, Bettinelli A, Borsa N et al. Long-term follow-up of patients with Bartter syndrome type I and II. Nephrol Dial Transplant 2010; 25: 2976-29781.
17. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405: 847-856. (Pubitemid 30407863)
18. Colhourn HM, McKeigue PM, Smith JD. Problems of reporting genetics associations with complex outcomes. Lancet 2003; 361: 865-872. (Pubitemid 36331853)
19. Vraki A, Geschwind DH, Eichler EE. Explaining human uniqueness: genome interactions with environment, behaviour and culture. Nature Rev Genet 2008; 9: 749-763.
20. Scott P, Ouimet D, Proulx Y et al. The 1 alpha hydroxylase locus is not linked to calcium stone formation or calciuric phenotype in French-Canadian families. J Am Soc Nephrol 1998; 9: 425-432. (Pubitemid 28122867)
21. Scott P, Ouimet D, Valiquette L et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol 1999; 10: 1007-1013. (Pubitemid 29203087)
22. Petrucci M, Scott P, Ouimet D et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int 2000; 58: 38-42. (Pubitemid 30429847)
23. Cailhier JF, Petrucci M, Valiquette L et al. Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis. J Urol 2001; 166: 1484-1486. (Pubitemid 32862224)
24. Khullar M, Relan V, Singh SK. VDR gene and urinary calcium excretion in nephrolithiasis. Kidney Int 2006; 69: 943.
25. Muller D, Hoenderop JGJ, Vennekens R et al. Epithelial Ca channel (ECAC1) in autosomal dominant idiopathic hypercalciuria. Nephrol Dial Transplant 2002; 17: 1614-1620. (Pubitemid 35012163)
26. Mossetti G, Rendina D, Viceconti R et al. The relationship of 30 vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis. Nephrol Dial Transplant 2004; 19: 2259-2265. (Pubitemid 39214119)
27. Bid HK, Kumar A, Kapoor R et al. Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. J Endourol 2005; 19: 111-115. (Pubitemid 40365756)
28. Huang CH, Wu WJ, Huang SP et al. Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis. BJU 2007; 99: 1534-1538.
29. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287. (Pubitemid 24051146)
30. Sugiyama T, Wang JC, Scott DK et al. Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promotertranscription factor I (COUP-TFI). J Biol Chem 2000; 275: 3446-3454.
31. Vezzoli G, Soldati L, Gambaro G. Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr Pharm Biotechnol 2009; 10: 302-310.
32. Hamilton DC, Grover VK, Smith C et al. Heterogeneous disease modeling for Hardy-Weinberg disequilibrium in case-control studies: application to renal stones and calcium-sensing receptor polymorphisms. Ann Hum Genet 2008; 73: 176-183.
33. Vezzoli G, Terranegra A, Arcidiacono T et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 2007; 71: 1155-1162. (Pubitemid 46809131)
34. Corbetta S, Eller-Vainicher C, Filopanti M et al. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur J Endocrinol 2006; 155: 687-692. (Pubitemid 44857492)
35. Vezzoli G, Terranegra A, Arcidiacono T et al. Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant 2010; 25: 2245-2252.
36. Arcidiacono T, Rainone F, Paloschi V et al. Polymorphisms of the calciumsensing receptor gene and stones in primary hyperparathyroidism. Arch Ital Urol Androl 2009; 81: 3.
37. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 2010; 25: 831-841.
38. Alam M, Kirton JP, Wilkinson FL et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 2009; 81: 260-268.
39. Gao B, Yasui T, Itoh Y et al. Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int 2007; 72: 592-598. (Pubitemid 47312789)
40. Liu CC, Huang SP, Tsai LY et al. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta 2010; 411: 739-743.
41. Suzuki Y, Pasch A, Bonny O et al. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 2008; 17: 1613-1618. (Pubitemid 351737165)
42. Gao B, Yasui T, Itoh Y et al. A polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol 2007; 177: 2361-2365. (Pubitemid 46726390)
43. Tsai FJ, Lin CC, Lu HF et al. Urokinase gene 30-UTR T/C polymorphism is associated with urolithiasis. Urology 2002; 59: 458-461.
44. Chen WC, Wu HC, Chen HY et al. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 2001; 29: 321-324.
45. Lai KC, Lin WY, Man KM et al. Association of interleukin-18 gene polymorphisms with calcium oxalate kidney stone disease. Scand J Urol Nephrol 2009; 44: 20-26.
46. Chen WC, Chen HY, Wu HC et al. Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res 2003; 31: 218-222.
47. Tsai FJ, Wu HC, Chen HY et al. Association of E-cadherin gene 3-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 2003; 70: 278-281.
48. Farber CR, Lusis AJ. Future of osteoporosis genetics: enhancing genome-wide association studies. J Bone Miner Res 2009; 24: 1937-1942.
49. Wolf MTF, Zalewski I, Martin FC et al. Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2-q34.2 by total genome search for linkage. Nephrol Dial Transplant 2005; 20: 909-914. (Pubitemid 40704026)
50. Kim YJ, Kim TH, Yun SJ et al. Renal phosphate control as a reliable predictive factor of stone recurrence. J Urol 2009; 181: 2566-2572.
51. Reed BY, Heller HJ, Gitomer WL et al. Mapping a gene defect in absorptive hypercalciuria to chromososme 1q23.3-q24. J Clin Endocrinol Metab 1999; 84: 3907-3913. (Pubitemid 30644173)
52. Reed BY, Gitomer WL, Heller HJ et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spine bone density. J Clin Endocrinol Metab 2002; 87: 1476-1485. (Pubitemid 34615225)
53. Muller D, Hoenderop JGJ, Vennekens R et al. Epithelial Ca channel (ECAC1) in autosomal dominant idiopathic hypercalciuria. Nephrol Dial Transplant 2002; 17: 1614-1620. (Pubitemid 35012163)
54. Thorleifsson G, Holm H, Edvardsson V et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009; 412: 926-930.
55. Weber S, Schneider L, Peters M et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001; 12: 1872-1881. (Pubitemid 32801362)
56. Hoopes RR, Middleton FA, Sen S et al. Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 2006; 17: 1292-1304. (Pubitemid 43673409)
57. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nature Rev Genet 2007; 8: 253-262. (Pubitemid 46439287)